At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 11 enrolled
Drug / intervention
LOKOMATdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Electrical Stimulation Induced Lower Limb Exercise Capacity, Cardiorespiratory Response, Cardiovascular Risk Factors and Muscle Activity Patterns in Response to Robotic Assisted Treadmill Gait Training in Individuals With Complete Motor Spinal Cord Injury
In Brief
A Phase 2 clinical trial evaluating LOKOMAT for Motor Complete Spinal Cord Injury. Completed, enrolled 11 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether a three times per week, 2 month robotic assisted treadmill gait training program, will beneficially affect the fitness, physical and psychological well-being, and the vascular and metabolic cardiovascular risk factors in individuals with complete motor Spinal Cord Injury (SCI).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMotor Complete Spinal Cord Injury
CountriesIsrael
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2011
First PostedMay 2011
Primary CompletionMay 2016
TodayJul 2026
First PostedMay 6, 2011
Enrollment StartMay 1, 2011
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 15.2 years ago
Interventions
LOKOMATdevice
Robot-assisted gait training,8 weeks,3 sessions a week,20-45 min each session.